OncoRock Therapeutics Inc.

CIK 2092566 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for OncoRock Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Oct 29, 2025D0002092566-25-000001